Glaucoma Stem Cell 2020

It is an exciting time for the adult stem cell field as the pace of new discoveries and understanding about how stem cells can be used for potential therapies is moving quickly.

Glaucoma stem cell 2020.

Retinal ganglion cell rgc apoptosis and optic nerve damage are the main pathological changes. Indianapolis more than 3 million americans have glaucoma a serious eye condition causing vision loss. Glaucoma is a neurodegenerative disease as a leading cause of global blindness. Unfortunately current treatments for glaucom.

Glaucoma physician september 2020 issue. However there are currently no fda approved stem cell treatments for glaucoma. Using human stem cell models researchers at indiana university school of medicine found they could analyze deficits within cells damaged by glaucoma with the potential to use this information to develop new strategies to slow the disease process. Patients with glaucoma should only consider receiving stem cell treatment in the context of a well regulated clinical trial after consultation with their personal ophthalmologist.

Hsin ya yang et al combination product of dermal matrix human mesenchymal stem cells and timolol promotes diabetic wound healing in mice stem cells translational medicine 2020. Glaucoma survey assesses disruption from coronavirus. Using human stem cell models researchers at indiana university school of medicine found they could. Patients have elevated intraocular pressure and progressive visual field loss.